Direct Presentation of Tumor‐Associated Antigens to Induce Adaptive Immunity by Personalized Dendritic Cell‐Mimicking Nanovaccines

Dendritic cells (DCs)‐based vaccines are an approved method for inducing potent antigen‐specific immune responses to eliminate tumor cells. However, this promising strategy still faces challenges such as tumor‐associated antigens (TAAs) loading, lymph node homing, quality control, and other limitati...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Advanced materials (Weinheim) 2022-11, Vol.34 (47), p.e2205950-n/a
Hauptverfasser:	Zhang, Jie, Fan, Biao, Cao, Guoliang, Huang, Wenping, Jia, Fuhao, Nie, Guangjun, Wang, Hai
Format:	Artikel
Sprache:	eng
Schlagworte:	antigen presentation Antigens cancer immunotherapy Customization dendritic cell Dendritic structure E coli Homing Immunity Interferon Lymphocytes Materials science Nanoparticles personalized vaccine Quality control Stimulators
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!